These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35355864)

  • 1. Fluorofenidone Inhibits UUO/IRI-Induced Renal Fibrosis by Reducing Mitochondrial Damage.
    Liao X; Lv X; Zhang Y; Han Y; Li J; Zeng J; Tang D; Meng J; Yuan X; Peng Z; Tao L; Xie Y
    Oxid Med Cell Longev; 2022; 2022():2453617. PubMed ID: 35355864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorofenidone attenuates renal fibrosis by inhibiting the mtROS-NLRP3 pathway in a murine model of folic acid nephropathy.
    Liao X; Jiang Y; Dai Q; Yu Y; Zhang Y; Hu G; Meng J; Xie Y; Peng Z; Tao L
    Biochem Biophys Res Commun; 2021 Jan; 534():694-701. PubMed ID: 33220928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorofenidone Attenuates Renal Interstitial Fibrosis by Enhancing Autophagy and Retaining Mitochondrial Function.
    Liu W; Zhou H; Dong H; Xing D; Lu M
    Cell Biochem Biophys; 2023 Dec; 81(4):777-785. PubMed ID: 37735328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorofenidone inhibits apoptosis of renal tubular epithelial cells in rats with renal interstitial fibrosis.
    Yang H; Zhang W; Xie T; Wang X; Ning W
    Braz J Med Biol Res; 2019; 52(11):e8772. PubMed ID: 31664306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorofenidone attenuates tubulointerstitial fibrosis by inhibiting TGF-β(1)-induced fibroblast activation.
    Yuan Q; Wang R; Peng Y; Fu X; Wang W; Wang L; Zhang F; Peng Z; Ning W; Hu G; Wang Z; Tao L
    Am J Nephrol; 2011; 34(2):181-94. PubMed ID: 21791914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorofenidone inhibits nicotinamide adeninedinucleotide phosphate oxidase via PI3K/Akt pathway in the pathogenesis of renal interstitial fibrosis.
    Qin J; Xie YY; Huang L; Yuan QJ; Mei WJ; Yuan XN; Hu GY; Cheng GJ; Tao LJ; Peng ZZ
    Nephrology (Carlton); 2013 Oct; 18(10):690-9. PubMed ID: 23841831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorofenidone attenuates oxidative stress and renal fibrosis in obstructive nephropathy via blocking NOX2 (gp91phox) expression and inhibiting ERK/MAPK signaling pathway.
    Qin J; Mei WJ; Xie YY; Huang L; Yuan QJ; Hu GY; Tao LJ; Peng ZZ
    Kidney Blood Press Res; 2015; 40(1):89-99. PubMed ID: 26029782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of fluorofenidone on renal interstitial fibrosis in rats with unilateral ureteral obstruction].
    Tan W; Wang W; Zheng X; Chen J; Yuan X; Zhang F; Wang S; Tao L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 May; 43(5):511-519. PubMed ID: 29886467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorofenidone Alleviates Renal Fibrosis by Inhibiting Necroptosis Through RIPK3/MLKL Pathway.
    Dai Q; Zhang Y; Liao X; Jiang Y; Lv X; Yuan X; Meng J; Xie Y; Peng Z; Yuan Q; Tao L; Huang L
    Front Pharmacol; 2020; 11():534775. PubMed ID: 33390935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorofenidone attenuates diabetic nephropathy and kidney fibrosis in db/db mice.
    Wang LH; Liu JS; Ning WB; Yuan QJ; Zhang FF; Peng ZZ; Lu MM; Luo RN; Fu X; Hu GY; Wang ZH; Tao LJ
    Pharmacology; 2011; 88(1-2):88-99. PubMed ID: 21847000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AKF-PD alleviates diabetic nephropathy via blocking the RAGE/AGEs/NOX and PKC/NOX Pathways.
    Qin J; Peng Z; Yuan Q; Li Q; Peng Y; Wen R; Hu Z; Liu J; Xia X; Deng H; Xiong X; Hu J; Tao L
    Sci Rep; 2019 Mar; 9(1):4407. PubMed ID: 30867431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxiredoxin 1 inhibits the oxidative stress induced apoptosis in renal tubulointerstitial fibrosis.
    Mei W; Peng Z; Lu M; Liu C; Deng Z; Xiao Y; Liu J; He Y; Yuan Q; Yuan X; Tang D; Yang H; Tao L
    Nephrology (Carlton); 2015 Nov; 20(11):832-42. PubMed ID: 25989822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Protective Effect of Fluorofenidone against Cyclosporine A-Induced Nephrotoxicity.
    Chen Y; Wang N; Yuan Q; Qin J; Hu G; Li Q; Tao L; Xie Y; Peng Z
    Kidney Blood Press Res; 2019; 44(4):656-668. PubMed ID: 31387101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirtuin 3 Activation by Honokiol Decreases Unilateral Ureteral Obstruction-Induced Renal Inflammation and Fibrosis via Regulation of Mitochondrial Dynamics and the Renal NF-κBTGF-β1/Smad Signaling Pathway.
    Quan Y; Park W; Jin J; Kim W; Park SK; Kang KP
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drp1-regulated PARK2-dependent mitophagy protects against renal fibrosis in unilateral ureteral obstruction.
    Li S; Lin Q; Shao X; Zhu X; Wu J; Wu B; Zhang M; Zhou W; Zhou Y; Jin H; Zhang Z; Qi C; Shen J; Mou S; Gu L; Ni Z
    Free Radic Biol Med; 2020 May; 152():632-649. PubMed ID: 31825802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulforaphane Protects against Unilateral Ureteral Obstruction-Induced Renal Damage in Rats by Alleviating Mitochondrial and Lipid Metabolism Impairment.
    Aranda-Rivera AK; Cruz-Gregorio A; Aparicio-Trejo OE; Tapia E; Sánchez-Lozada LG; García-Arroyo FE; Amador-Martínez I; Orozco-Ibarra M; Fernández-Valverde F; Pedraza-Chaverri J
    Antioxidants (Basel); 2022 Sep; 11(10):. PubMed ID: 36290577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redox signaling pathways in unilateral ureteral obstruction (UUO)-induced renal fibrosis.
    Aranda-Rivera AK; Cruz-Gregorio A; Aparicio-Trejo OE; Ortega-Lozano AJ; Pedraza-Chaverri J
    Free Radic Biol Med; 2021 Aug; 172():65-81. PubMed ID: 34077780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorofenidone protects liver against inflammation and fibrosis by blocking the activation of NF-κB pathway.
    Tu S; Jiang Y; Cheng H; Yuan X; He Y; Peng Y; Peng X; Peng Z; Tao L; Yang H
    FASEB J; 2021 Jul; 35(7):e21497. PubMed ID: 34152015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-renal fibrosis effect of asperulosidic acid via TGF-β1/smad2/smad3 and NF-κB signaling pathways in a rat model of unilateral ureteral obstruction.
    Xianyuan L; Wei Z; Yaqian D; Dan Z; Xueli T; Zhanglu D; Guanyi L; Lan T; Menghua L
    Phytomedicine; 2019 Feb; 53():274-285. PubMed ID: 30668407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorofenidone attenuates hepatic fibrosis by suppressing the proliferation and activation of hepatic stellate cells.
    Peng Y; Yang H; Wang N; Ouyang Y; Yi Y; Liao L; Shen H; Hu G; Wang Z; Tao L
    Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(3):G253-63. PubMed ID: 24337009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.